CPT code 83015 represents a qualitative laboratory assay that detects the presence and identity of heavy metals in blood, urine, or other body substances without reporting concentrations. This test is clinically relevant for toxicology screening, occupational exposure assessment, forensic investigations, and targeted follow-up when specific metal exposure is suspected. Nationally, qualitative heavy metal identification supports public health surveillance and clinical decision-making when rapid presence/absence information is needed.

Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and where this service fits within laboratory toxicology workflows. The publication summarizes coding practice essentials, common modifiers associated with laboratory services, and expected service settings. It highlights what to expect for coverage considerations at a national level, operational implications for laboratories, and the clinical scenarios in which a qualitative identification test is ordered.

The content is intended to orient clinicians, billing professionals, and policy analysts to the purpose and use of CPT code 83015, clarify the type of information returned by the test, and outline the practical contexts in which the code is applied.